You have clicked on a link intended for US healthcare professionals only.
Are you a US healthcare professional?
In order to download this Reimbursement Tool, you must be a US healthcare professional.
Are you a US healthcare professional?
By clicking this link, you'll leave TESTOPEL.com and open a site not sponsored by Endo Pharmaceuticals Inc. Endo Pharmaceuticals Inc. does not review
or control the content of sites
it does not own and disclaims responsibility
for content therein. Would you like to continue?
By clicking this link, you'll be leaving TESTOPEL®.com.
Would you like to continue?
TESTOPEL® slowly releases testosterone into the body for 3 to 4 months, and sometimes up to 6 months.
No. Because TESTOPEL® pellets are implanted by a healthcare provider under the skin, not applied topically to the skin, TESTOPEL® cannot be transferred to others during physical contact. Because testosterone is a hormone that regulates sexual growth, such transfer can cause problems for women and children.
A healthcare provider at your doctor’s office implants TESTOPEL® pellets just under the skin in the hip area or another fatty area.
TESTOPEL®, relative to a dime, is shown below.
Side effects of TESTOPEL® include more erections than normal or erections that last a long time, nausea, vomiting, changes in skin color, ankle swelling, changes in body hair, male pattern baldness, acne, suppression of certain clotting factors, bleeding in patients on blood thinners, increase or decrease in sex drive, headache, anxiety, depression, inflammation and pain at the implantation site and, rarely, anaphylactoid reaction (a sudden onset of allergic reaction).
Serious side effects associated with abuse of testosterone and anabolic androgenic steroids include cardiac arrest, myocardial infarction, hypertrophic cardiomyopathy, congestive heart failure, cerebrovascular accident, hepatotoxicity, and serious psychiatric manifestations, including major depression, mania, paranoia, psychosis, delusions, hallucinations, hostility and aggression.
Yes. Men should not receive TESTOPEL® or any form of testosterone replacement therapy if they have known or suspected prostate cancer or breast cancer, or have had an adverse reaction to the product. Also, pregnant women or women trying to get pregnant should not use TESTOPEL® or any testosterone replacement therapy.
A doctor's office experienced with prescribing TESTOPEL® can work with you to explore your benefit coverage.